As the fourth third-party allotment under the Equity Program, 2,932,000 ordinary shares were issued with payment completed. Additionally, 29,320 stock acquisition rights were issued; the exercise period is 2026\/10\/21\u20132030\/10\/18. The total funds to be raised from the shares and stock acquisition rights exceed 1,960 million yen. The registration for issuance has been withdrawn.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4978","jir_company_name":"ReproCELL Incorporated","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4978-20261020-01.pdf","jir_short_summary":"As the fourth third-party allotment under the Equity Program, 2,932,000 ordinary shares were issued with payment completed. Additionally, 29,320 stock acquisition rights were issued; the exercise period is 2026\/10\/21\u20132030\/10\/18. The total funds to be raised from the shares and stock acquisition rights exceed 1,960 million yen. The registration for issuance has been withdrawn.","jir_summary":"### Overview of Capital Policy\nUnder the Equity Program Agreement with CVI Investments, Inc., the Company issued 2,932,000 ordinary shares as the fourth third-party allotment at an issue price of 119 yen, and the total proceeds amounted to 348,908,000 yen. In addition, 29,320 stock acquisition rights were issued with an exercise period from 2026\/10\/21 to 2030\/10\/18 and an exercise price of 159 yen. This is expected to increase capital stock by 174,454,000 yen and capital surplus by 174,454,000 yen. After completion of payment, the registration for issuance has been withdrawn.\n\n### Future Impact and Information\nThis third-party allotment and issuance of stock acquisition rights are part of the capital policy, aiming to strengthen the capital structure through fundraising and an increase in potential shares. The total amount of capital raised may change depending on the exercise of the stock acquisition rights, and actual funds received will depend on exercise outcomes. The withdrawn registration for issuance indicates that the offering was completed. Continued attention is required for future disclosures and developments in applicable conditions.","jir_financial_highlights":"Number of Newly Issued Shares: 2,932,000 shares (Unknown)\nIssue Price (Ordinary Shares): 119 yen (Unknown)\nAmount of Capital Increase: 174,454,000 yen (Unknown)\nNumber of Stock Acquisition Rights Issued: 29,320 cases (Unknown)\nExercise Price of Stock Acquisition Rights: 159 yen per share (Unknown)","jir_category":"","jir_hashtags":"#ReproCELL, #ShareBuyback, #StockAcquisitionRights, #CapitalPolicy","jir_key_figures":"2,932,000 shares: Number of ordinary shares issued\n119 yen: Issue price (ordinary shares)\n174,454,000 yen: Amount of capital increase\n29,320 cases: Number of stock acquisition rights issued\n159 yen: Exercise price (stock acquisition rights)","jir_meta_title":"ReproCELL \u2014 Completion of Share Issuance and Stock Acquisition Rights Payment & Withdrawal of Registration\uff5cOctober 2026","jir_meta_description":"ReproCELL completed the fourth third-party allotment under its Equity Program, issuing 2,932,000 ordinary shares and 29,320 stock acquisition rights. Payment completion and withdrawal of issuance registration announced. Details and potential impact on capital structure explained.","jir_og_title":"ReproCELL \u2014 Completion of Share Issuance and Stock Acquisition Rights Payment & Withdrawal of Registration\uff5cOctober 2026","jir_og_description":"ReproCELL issued 2,932,000 ordinary shares and 29,320 stock acquisition rights in the fourth third-party allotment. Payment completion and registration withdrawal announced. Key capital policy points summarized.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58459,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-132924","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n